Pituitary function is altered during the same cycle in women with polycystic ovary syndrome treated with continuous or cyclic oral contraceptives or a gonadotropin-releasing hormone agonist
- 1 July 1996
- journal article
- Published by Elsevier in Fertility and Sterility
- Vol. 66 (1) , 54-60
- https://doi.org/10.1016/s0015-0282(16)58387-3
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Polycystic ovarian syndrome and associated hirsutism in the adolescentAdolescent and Pediatric Gynecology, 1992
- Relevance of Biological Properties of Progestogen of Oral Contraceptives in Treatment of Androgen Excess SymptomsJournal of Clinical Endocrinology & Metabolism, 1990
- Potential utility of gonadotropin-releasing hormone agonists in the management of ovarian hyperandrogenismFertility and Sterility, 1990
- Clinical and Hormonal Effects of Chronic Gonadotropin Releasing Hormone Agonist Treatment in Polycystic Ovarian Disease*Journal of Clinical Endocrinology & Metabolism, 1987
- ON THE SITE OF ACTION OF PROGESTERONE IN THE BLOCKADE OF THE ESTRADIOL-INDUCED GONADOTROPIN DISCHARGE IN THE RHESUS MONKEY1Endocrinology, 1981
- Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome.Journal of Clinical Investigation, 1976
- Evaluation of the Obese PatientJAMA, 1976
- The effectiveness of two oral contraceptives in suppressing plasma androstenedione, testosterone, LH, and FSH, and in stimulating plasma testosterone-binding capacity in hirsute womenAmerican Journal of Obstetrics and Gynecology, 1976
- Inappropriate Secretion of Follicle-Stimulating Hormone and Luteinizing Hormone in Polycystic Ovarian DiseaseJournal of Clinical Endocrinology & Metabolism, 1970
- The Polycystic Ovary. I. Clinical and Histologic FeaturesJournal of Clinical Endocrinology & Metabolism, 1962